SHANGHAI, China and CUPERTINO, Calif., Nov. 28, 2016 — Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biomedicine firm engaged in the development of effective immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced that a scientific presentation will be made at the World Stem Cell Summit to be held in West Palm Beach on December 6th-9th, 2016, regarding its advanced mesenchymal progenitor cell (MPC) therapy.
Title: Regeneration of Cartilage by Human Adipose-derived MPC Treatment for Knee Osteoarthritis
Presentation: Thursday, December 8, 11:00AM – 12:00PM EST
Location: Meeting Room 1 G/H, Palm Beach County Convention Center, West Palm Beach, Florida
Presenter: Dr. Richard Wang, Chief Operating Officer of Cellular Biomedicine Group
Following the conference, an archived presentation will be available on the Company website here: http://www.cellbiomedgroup.com/investor-relations/presentations/.
About Cellular Biomedicine Group (CBMG)
Cellular Biomedicine Group, Inc. develops proprietary cell therapies for the treatment of cancer and degenerative diseases. Our immuno-oncology and stem cell projects are the result of research and development by CBMG’s scientists and clinicians from both China and the United States. Our GMP…